Drug-induced expansion of infarct: morphologic and functional correlations

Circulation
|March 1, 1984
PubMed

Insights

Indomethacin treatment after coronary occlusion reduced myocardial infarct expansion and preserved left ventricular function in dogs. This finding highlights the impact of early anti-inflammatory drug intervention on cardiac remodeling and function post-infarction.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Cardiac Remodeling

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids can affect myocardial scar formation post-coronary occlusion.
  • Early intervention may influence infarct expansion and subsequent ventricular function.

Purpose of the Study:

  • To investigate the effect of indomethacin on left ventricular infarct expansion in the early phase after coronary occlusion.
  • To determine if infarct expansion influences ventricular function.

Main Methods:

  • A blinded, randomized study in 17 dogs with experimentally induced myocardial infarction.
  • Treatment group received intravenous indomethacin; control group received saline.
  • Echocardiography and post-mortem heart examination were used to assess infarct size, expansion, and regional function after 7 days.

Main Results:

  • Indomethacin significantly reduced the ratio of infarct wall thickness to non-infarcted wall thickness (0.96 vs 1.20).
  • Indomethacin treatment led to a higher expansion index (1.29 vs 1.02), indicating reduced infarct expansion.
  • Dogs with infarct expansion showed significantly lower regional ventricular function (% delta A: 28.7% vs 46.8%).

Conclusions:

  • Early administration of indomethacin interferes with myocardial infarct expansion.
  • Reduced infarct expansion is associated with better preservation of regional left ventricular function.
  • These findings suggest a potential therapeutic window for NSAIDs in managing early cardiac remodeling after myocardial infarction.